Show simple item record

dc.contributor.authorCamilo, Ashley N.
dc.contributor.authorKashalikar, Neha
dc.contributor.authorPomfret, Thomas C.
dc.contributor.authorFaber, Donna M.
dc.contributor.authorLenz, Kimberly J.
dc.contributor.authorGoldstein, Joel
dc.contributor.authorClements, Karen M.
dc.contributor.authorAngelini, Michael
dc.contributor.authorLeto, Patricia
dc.contributor.authorJeffrey, Paul L.
dc.date2022-08-11T08:08:07.000
dc.date.accessioned2022-08-23T15:43:11Z
dc.date.available2022-08-23T15:43:11Z
dc.date.issued2017-03-27
dc.date.submitted2017-07-17
dc.identifier.doi10.13028/zn35-2m73
dc.identifier.urihttp://hdl.handle.net/20.500.14038/27029
dc.description<p>Presented at Academy of Managed Care and Specialty Pharmacy Annual Conference 2017.</p> <p>Client/Partner: <a href="https://commed.umassmed.edu/clientpartner/executive-office-health-and-human-services">Executive Office of Health and Human Services</a></p>
dc.description.abstractIn 2011, the U.S. Government Accountability Office (GAO) reported foster and non-foster children in the MassHealth, Massachusetts Medicaid program, exhibited the highest rate of behavioral health medication (BHM) utilization, with 49.3% of all Medicaid children being prescribed a psychotropic medication, and 39.1% of children in foster care prescribed these medications. The MassHealth Pharmacy Program, which is managed by UMass Medical School, implemented a PBHMI Workgroup in November 2014 with the collaboration of the Department of Children and Families and the Department of Mental Health. The workgroup proactively requires prior authorization (PA) for specific medications or combinations of BHMs prescribed to members less than 18 years of age. Interventions include telephonic prescriber outreach by a child/adolescent psychiatrist to discuss opportunities for regimen simplification, drug interactions or toxicity, and to encourage evidence-based practices. An analysis of the workgroup suggests a peer-to-peer outreach program is associated with increased awareness and implementation of evidence based medicine in a pediatric population treated with behavioral health medications.
dc.language.isoen_US
dc.rights© 2017 University of Massachusetts Medical School
dc.subjectfoster care
dc.subjectMassHealth
dc.subjectbehavioral health medications
dc.subjectMedicaid
dc.subjectprescribing
dc.subjectHealth Policy
dc.subjectHealth Services Administration
dc.subjectHealth Services Research
dc.subjectPediatrics
dc.subjectPharmacy and Pharmaceutical Sciences
dc.subjectPsychiatric and Mental Health
dc.subjectPsychiatry and Psychology
dc.titleEvaluating the Impact of Interventions by a Multidisciplinary Pediatric Behavioral Health Medication Initiative Workgroup on Medication Prescribing Trends in a Medicaid Population
dc.typePoster
dc.identifier.legacyfulltexthttps://escholarship.umassmed.edu/cgi/viewcontent.cgi?article=1031&amp;context=commed_pubs&amp;unstamped=1
dc.identifier.legacycoverpagehttps://escholarship.umassmed.edu/commed_pubs/37
dc.identifier.contextkey10439622
refterms.dateFOA2022-08-23T15:43:11Z
html.description.abstract<p>In 2011, the U.S. Government Accountability Office (GAO) reported foster and non-foster children in the MassHealth, Massachusetts Medicaid program, exhibited the highest rate of behavioral health medication (BHM) utilization, with 49.3% of all Medicaid children being prescribed a psychotropic medication, and 39.1% of children in foster care prescribed these medications.</p> <p>The MassHealth Pharmacy Program, which is managed by UMass Medical School, implemented a PBHMI Workgroup in November 2014 with the collaboration of the Department of Children and Families and the Department of Mental Health.</p> <p>The workgroup proactively requires prior authorization (PA) for specific medications or combinations of BHMs prescribed to members less than 18 years of age. Interventions include telephonic prescriber outreach by a child/adolescent psychiatrist to discuss opportunities for regimen simplification, drug interactions or toxicity, and to encourage evidence-based practices.</p> <p>An analysis of the workgroup suggests a peer-to-peer outreach program is associated with increased awareness and implementation of evidence based medicine in a pediatric population treated with behavioral health medications.</p>
dc.identifier.submissionpathcommed_pubs/37
dc.contributor.departmentCommonwealth Medicine
dc.contributor.departmentClinical Pharmacy Services
dc.contributor.departmentCenter for Health Policy and Research


Files in this item

Thumbnail
Name:
UMASS_Poster_AMCP2017_CPS_2017 ...
Size:
426.3Kb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record